Editorial [Biomarker Translation and Personalized Medicine - Context, Reality and a Call for Enhanced Validation]

E-ISSN： 1875-6913|8|3|171-173

ISSN： 1875-6921

Source： Current Pharmacogenomics and Personalized Medicine (Formerly Current Pharmacogenomics), Vol.8, Iss.3, 2010-09, pp. : 171-173

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Biomarker Diversity, Validation and Clinical Translation: Tenets for Emergent Personalized Medicine Initiatives

Current Pharmacogenomics and Personalized Medicine (Formerly Current Pharmacogenomics), Vol. 9, Iss. 4, 2011-12 ,pp. : 286-298

Bentham Science Publishers

Access to resources Recommend Favorite

Editorial Personalized Medicine in Inflammatory Bowel Diseases: Myth or Reality?

Current Drug Targets, Vol. 19, Iss. 7, 2018-04 ,pp. : 721-721

Bentham Science Publishers

Access to resources Recommend Favorite

Genetic biomarkers in personalized medicine Genetische Biomarker in der stratifizierten Arzneimitteltherapie

By Dingermann Theo Zündorf Ilse

PHARMAKON, Vol. 1, Iss. 1, 2013-01 ,pp. : 12-20

Govi-Verlag

Access to resources Recommend Favorite

Editorial (Personalized Medicine in Developing Countries: A Roadmap to Personalized Innovation)

Current Pharmacogenomics and Personalized Medicine (Formerly Current Pharmacogenomics), Vol. 9, Iss. 3, 2011-01 ,pp. : 156-158

Bentham Science Publishers

Access to resources Recommend Favorite

A Broader Perspective on Personalized Medicine: Lessons from Discourse Analysis and Knowledge Translation

Current Pharmacogenomics and Personalized Medicine (Formerly Current Pharmacogenomics), Vol. 10, Iss. 3, 2012-09 ,pp. : 179-181

Bentham Science Publishers

Access to resources Recommend Favorite